# AllMeds.ai

> AI-powered medication risk intelligence and pharmacy-style medication reviews. Two audiences served by one platform: individuals and carers managing their own or a loved one's medications, and case managers, rehab providers, insurers, and scheme operators managing personal injury claims.

AllMeds was built by registered pharmacists. It is used by 4,000+ consumers and case managers each month across Australia, the United Kingdom, and the United States. Content on the public website is informational only and is not medical advice.

## What AllMeds Does

- For individuals and carers: pharmacy-style medication reviews. Upload a prescription or type your medications. Get an instant interaction check, suitability commentary, and a referral letter for your GP.
- For case managers and insurers: full medication risk assessment on every claim. Injury-relatedness scoring (also known as reasonable and necessary), compliance reports against TGA / FDA / MHRA / SIRA / NICE / CDC, and automated letters to treating doctors. Per-claim cost attribution.

## Product Capabilities

- Medication risk assessment with severity scoring across 4,489+ drugs in TGA, FDA, and MHRA databases
- Drug interaction detection for any combination of medications, with severity and clinical mechanism
- Injury-relatedness scoring (injury-related, partially related, not related) for compensable injury claims
- Compliance reports against TGA, FDA, MHRA, SIRA, WorkSafe, NICE, CDC, BPAC NZ guidelines
- Automated, evidence-based letters to treating GPs and specialists
- Work capacity analysis covering medication effects on return to work and driving fitness
- API and MCP integrations for ChatGPT, Claude.ai, and case management systems

## Drug Database Coverage

- 4,489 medications with cross-jurisdiction regulatory data
- TGA scheduling (Australia): S2, S3, S4, S8 classifications across 3,040 drugs
- FDA approved (United States): 2,576 drugs
- MHRA data (United Kingdom)
- Risk levels: minimal, low, moderate, high, critical
- Pharmacological properties: CNS depressant, serotonergic, respiratory depression risk, QTc prolonging, opioid OME factors
- Drug classes covered: opioids, benzodiazepines, gabapentinoids, GLP-1 receptor agonists, antidepressants, antipsychotics, NSAIDs, muscle relaxants, biologics, peptides, antihypertensives

## Consumer Education Library

The site publishes regulator-sourced, references-only education pages. No advice. Each page summarises what FDA, EMA, TGA, MHRA, NICE, or peer-reviewed sources have said about the medicine or peptide.

### GLP-1 receptor agonists (weight management and type 2 diabetes)
- /side-effects/glp-1 - GLP-1 class side-effects hub
- /side-effects/ozempic-side-effects - Ozempic (semaglutide) FDA label
- /side-effects/wegovy-side-effects - Wegovy (semaglutide for weight management) FDA label
- /side-effects/mounjaro-side-effects - Mounjaro (tirzepatide) FDA label
- /side-effects/zepbound-side-effects - Zepbound (tirzepatide for weight management) FDA label
- /side-effects/tirzepatide-side-effects - Tirzepatide active-ingredient guide
- /side-effects/semaglutide-side-effects - Semaglutide active-ingredient guide
- /side-effects/trulicity-side-effects - Trulicity (dulaglutide) FDA label
- /side-effects/rybelsus-side-effects - Rybelsus (oral semaglutide) FDA label
- /side-effects/victoza-side-effects - Victoza (liraglutide for T2D) FDA label
- /side-effects/saxenda-side-effects - Saxenda (liraglutide for weight management) FDA label
- /side-effects/retatrutide-side-effects - Retatrutide (investigational triple agonist)
- /interactions/ozempic-and-alcohol, /interactions/ozempic-and-metformin, /interactions/ozempic-and-insulin, /interactions/ozempic-and-antidepressants, /interactions/ozempic-and-birth-control, /interactions/ozempic-and-ibuprofen, /interactions/ozempic-and-levothyroxine
- /interactions/mounjaro-and-alcohol, /interactions/mounjaro-and-metformin, /interactions/mounjaro-and-insulin, /interactions/mounjaro-and-antidepressants, /interactions/mounjaro-and-birth-control, /interactions/mounjaro-and-ibuprofen, /interactions/mounjaro-and-levothyroxine
- /interactions/wegovy-and-alcohol, /interactions/wegovy-and-metformin, /interactions/wegovy-and-insulin, /interactions/wegovy-and-antidepressants, /interactions/wegovy-and-birth-control
- /interactions/tirzepatide-drug-interactions, /interactions/semaglutide-drug-interactions
- /interactions/can-you-drink-on-ozempic, /interactions/ozempic-interactions
- /weight-loss-injections - FDA-approved weight-loss injections explained

### Peptide safety
- /peptides - Are peptides safe? Regulator-sourced peptide safety hub
- /peptide-therapy - What peptide therapy means in practice
- /growth-hormone-peptides - GHRH analogues and ghrelin-receptor secretagogues
- /peptides/are-peptides-legal - US, AU, UK, and EU regulatory status
- /peptides/peptide-injections-side-effects - Cross-peptide injection risks
- /peptides/bpc-157-side-effects, /peptides/bpc-157-benefits, /peptides/bpc-157-dosage, /peptides/bpc-157-before-and-after
- /peptides/cjc-1295-side-effects, /peptides/cjc-1295-dosage, /peptides/cjc-1295-ipamorelin-side-effects, /peptides/cjc-1295-ipamorelin-dosage
- /peptides/ipamorelin-side-effects, /peptides/ipamorelin-dosage
- /peptides/sermorelin-side-effects, /peptides/sermorelin-benefits, /peptides/sermorelin-dosage
- /peptides/tb-500-side-effects, /peptides/tb-500-benefits, /peptides/tb-500-dosage
- /peptides/aod-9604-side-effects, /peptides/aod-9604-dosage
- /peptides/pt-141-side-effects, /peptides/pt-141-dosage
- /peptides/igf-1-side-effects
- /peptides/tesamorelin-side-effects, /peptides/tesamorelin-dosage
- /peptides/ibutamoren-side-effects, /peptides/ibutamoren-benefits (MK-677)
- /peptides/ghk-cu-side-effects, /peptides/ghk-cu-dosage
- /peptides/mots-c-side-effects, /peptides/mots-c-dosage
- /peptides/dsip-side-effects, /peptides/thymosin-alpha-1-side-effects
- /peptides/semax-side-effects, /peptides/selank-side-effects, /peptides/epitalon-side-effects, /peptides/kisspeptin-side-effects
- /peptides/hexarelin-side-effects, /peptides/ghrp-2-side-effects, /peptides/ghrp-6-side-effects
- /peptides/follistatin-side-effects, /peptides/melanotan-2-side-effects

### Drug interactions and safety
- /drug-interaction-checker - Free drug interaction checker. 92,005+ TGA-registered medicines.
- /resources/can-you-take-endone-with-valium, /resources/can-you-take-tramadol-with-panadeine-forte
- /resources/is-lyrica-schedule-8-australia, /resources/what-schedule-is-endone-australia, /resources/what-schedule-is-panadeine-forte-australia, /resources/what-schedule-is-tramadol-australia
- /resources/is-tramadol-appropriate-ankle-sprain
- /resources/opioid-prescribing-crisis-australian-workers-compensation
- /resources/medicinal-cannabis-workers-compensation-australia
- /resources/medication-overcharging-detection-guide, /resources/detect-medication-overcharging-workers-compensation
- /resources/workplace-medication-safety-compliance-checklist
- /resources/australian-workers-compensation-guide-2025, /resources/australian-workers-compensation-medication-cost-crisis, /resources/australian-workers-compensation-research-findings
- /resources/ctp-claims-medical-cost-management-strategies
- /resources/mining-industry-workers-compensation-medication-claims
- /resources/self-insured-mining-companies-workers-compensation-medication-costs

## Jurisdictions and Regulatory Guidelines Indexed

### Australia
- NSW: SIRA Medication Management Better Practice Guide, SIRA Whiplash Guidelines, SIRA Best Practice Opioid Management, SIRA Workers Compensation Guidelines
- VIC: WorkSafe Victoria guidelines
- QLD: WorkCover QLD Clinical Framework for Delivery of Health Services
- WA: WorkCover WA guidelines
- SA: ReturnToWorkSA guidelines
- TAS: WorkSafe Tasmania Guide to Workers Rehab and Compensation
- Federal: Comcare National Clinical Framework
- PBS (Pharmaceutical Benefits Scheme) medication data

### United Kingdom
- NICE NG193: Chronic Pain (Primary and Secondary) in Over 16s
- NICE NG59: Low Back Pain and Sciatica in Over 16s
- NICE NG100: Rheumatoid Arthritis in Adults
- NICE NG226: Osteoarthritis in Adults
- NICE CG173: Neuropathic Pain in Adults
- NICE CG150: Headaches in Over 12s
- NICE CG140: Opioids in Palliative Care
- FPM Opioids Aware Dose Equivalents, Structured Approach, and Surgery and Opioids guidelines
- MHRA Drug Safety Updates
- NHS England medicines optimisation guidance

### United States
- FDA prescribing information (Drugs@FDA)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022)
- CDC Opioid Prescribing Recommendations

### European Union
- EMA EPAR product information

### New Zealand
- BPAC NZ Opioid Prescribing guides
- Medsafe prescribing guidelines

## Who Uses AllMeds

- Individuals and carers managing prescriptions for themselves or a loved one
- Case managers and claims handlers in workers compensation, CTP, and personal injury
- Rehabilitation providers and consultants
- Return to work coordinators
- Injury management consultants
- Nurse case managers
- Occupational health advisors
- Support workers and care workers
- Independent and solo practitioners
- Scheme operators and insurers
- Medical-legal professionals and solicitors
- NDIS support coordinators

## Pricing

Two audience tracks with a toggle on the pricing page.

### For individuals and carers (self-serve via app.allmeds.ai)
- One-off review: $10 USD per pharmacy-style review (up to 40 medications). No subscription.
- Standard subscription: $15 USD per month (5 reviews per month) or $10 USD per month billed annually (60 reviews per year). Most popular.
- Plus subscription: $25 USD per month (15 reviews per month) or $17 USD per month billed annually (180 reviews per year). Includes API and MCP access, priority pharmacist support.

### For teams and insurers (custom commercial terms)
- Per-Assessment: pay per medication review with per-claim line-item attribution. Includes risk scoring, injury-relatedness checks, compliance reports, automated letters, and API and MCP integration.
- Enterprise: bulk procurement, portfolio reporting, quarterly medication health checks, quarterly waste, fraud and abuse reports, SSO, dedicated pharmacist and account manager.

## Calls to action

- Try it free: https://app.allmeds.ai
- Talk to Sales: https://allmeds.ai/book-demo

## Editorial position

- Not medical advice. All content is informational and references regulator statements or peer-reviewed literature.
- Speak to your doctor or pharmacist before starting, stopping, or changing any medicine.
- Peptide safety pages reframe gray-market keywords (dosage, before and after, benefits) into evidence-audit content rather than publishing protocols.
- Peptide pages explicitly cite the FDA position on compounded substances of significant safety concern, the WADA prohibited list, and MHRA / TGA warnings where they apply.
- GLP-1 pages cite current FDA prescribing information including the boxed warning for thyroid C-cell tumours and labelled risks for pancreatitis, gallbladder disease, kidney injury, hypoglycaemia with insulin or sulfonylureas, and aspiration risk during anaesthesia.

## Contact

- Website: https://allmeds.ai
- Free tool: https://app.allmeds.ai
- Talk to Sales: https://allmeds.ai/book-demo
- Email: hello@allmeds.ai